Special Problems of the Diabetic Patient

  • Wilhelm Krone
  • Dirk Müller-Wieland

Abstract

Diabetes mellitus is a common disease in the western world, affecting 2–5% of the general population. An important complication of the disease is the development of ulcers and gangrene of the lower limb. The management of these patients is an enormous health problem due to their long periods as in-patient and an amputation rate about 15 times higher than in non-diabetic subjects [1].

Keywords

Cholesterol Catheter Corn Europe Lipase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Most RS, Sinnock P (1983) The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6:87–91PubMedCrossRefGoogle Scholar
  2. 2.
    Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Schowstack J A (1989) Lower-extremity amputation in people with diabetes mellitus. Epidemiology and prevention. Diabetes Care 12:24–31PubMedCrossRefGoogle Scholar
  3. 3.
    Brand FN, Abbott RD, Kannel WB, (1989) Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 38:504–509PubMedCrossRefGoogle Scholar
  4. 4.
    Members of the Working Group on Hypertension in Diabetes (1987) Statement on hypertension in diabetes. Diabetes Care 10:764–776CrossRefGoogle Scholar
  5. 5.
    Assmann G, Schulte H (1988) The Prospective Cardiovascular Münster (PROCAM) Study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Amer Heart J116, part 2:1713–1724CrossRefGoogle Scholar
  6. 6.
    Study Group, European Atherosclerosis Society (1988) The recognition and management of hyperlipidemia in adults: a policy statement of the European Atherosclerosis Society. Amer Heart J 9:571–600Google Scholar
  7. 7.
    Stout RW (1979) Diabetes and atherosclerosis: the role of insulin. Diabetologia 167:141–150CrossRefGoogle Scholar
  8. 8.
    Wirth A, Krone W (1988) Insulin: ein kardiovaseularer Risikofaktor. Dtsch Med Wochenschr 113:1250–1254PubMedGoogle Scholar
  9. 9.
    Kannel WB, McGee DL (1985) Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Amer Geriatr Soe 33:13–18Google Scholar
  10. 10.
    Hatary Y (1987) Diabetic peripheral neuropathy. Ann Intern Med 107:546–559Google Scholar
  11. 11.
    Louie TJ, Artlett JG, Tally FP (1976) Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 85:461–463PubMedGoogle Scholar
  12. 12.
    Krolewski AS, Warram JH, Rand LI, Kahn CR (1987) Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390–1398PubMedCrossRefGoogle Scholar
  13. 13.
    Bingley PJ, Gale EAM (1989) Rising incidence of IDDM in Europe. Diabetes Care 12:289–295PubMedCrossRefGoogle Scholar
  14. 14.
    Krolewski AS, Warram JH (1985) Epidemiology of diabetes mellitus. In: Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS (eds) Joslin’s diabetes mellitus, 12th ed. Philadelphia, Lea & Febiger, pp 12–42Google Scholar
  15. 15.
    Gutman M, Kaplan O, Skornick Y, Klausner JM, Lelcuk S, Rozin RR (1987) Gangrene of the lower limbs in diabetic patients: a malignant complication. Am J Surg 154:305–308PubMedCrossRefGoogle Scholar
  16. 16.
    Mogensen CE (1988) Therapeutic interventions in nephropathy of IDDM. Diabetes Care 11 (suppl 1): 10–15PubMedGoogle Scholar
  17. 17.
    Ganda OP (1985) Pathogenesis of macrovascular disease including the influence of lipids. In: Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS (eds) Joslin’s diabetes mellitus, 12th ed. Philadelphia, PA, Lea & Febiger, pp 217–250Google Scholar
  18. 18.
    Howard BV (1987) Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613–628PubMedGoogle Scholar
  19. 19.
    Kostner GM, Karachi I (1988) Lipoprotein alterations in diabetes mellitus. Diabetologia 31:717–722PubMedCrossRefGoogle Scholar
  20. 20.
    Krone W, Nägele H, Behnke B, Greten H (1988) Opposite effects of insulin and catecholamines on LDL-receptor activity in human mononuclear leukocytes. Diabetes 37:1386–1391PubMedCrossRefGoogle Scholar
  21. 21.
    Jarrett RJ, Keen H, Chakrabati R (1982) Diabetes, hyperglycemia and arterial disease. In: Keen H, Jarrett J (eds) Complications of diabetes, 2nd ed. London, Edward Arnold, Ltd, pp 179–203Google Scholar
  22. 22.
    Klaff LJ, Palmer JP (1986) Risk for developing cardiovascular risk factors: risk for glucose intolerance. Cardiol Clin 4:67–73PubMedGoogle Scholar
  23. 23.
    Brownly M, Cerami A (1981) The biochemistry of the complications of diabetes mellitus. Ann Rev Biochem 50:385–432CrossRefGoogle Scholar
  24. 24.
    Brownly M, Cerami A, Vlassara H (1988) Advanced glycosilation endproducts in tissue in the biochemical basis of diabetic complications. New Engl J Med 318:1315–1321CrossRefGoogle Scholar
  25. 25.
    Edmonds ME (1986) The diabetic foot: pathophysiology and treatment. Clin Endocrinol Metab 15:899–916CrossRefGoogle Scholar
  26. 26.
    Colwell JA, Lopes-Virella MF (1988) A review of the development of large-vessel disease in diabetes mellitus. Am J Med 85 (Suppl): 113–118PubMedCrossRefGoogle Scholar
  27. 27.
    Cooppan R (1985) Infection in diabetes. In: Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS (eds) Joslin’s diabetes mellitus, 12th ed. Philadelphia, Lea & Febiger, pp 737–747Google Scholar
  28. 28.
    Strian F (1986) Autonome und sensomotorische Diabetesneuropathie-diagnostische und klassifikatorische Probleme. In: Strian F, Haslbeck M (eds) Autonome Neuropathie. Springer, pp 3–14Google Scholar
  29. 29.
    Möller A, Haslbeck M (1986) Trophische Störungen. In: Strian F, Haslbeck M (eds) Autonome Neuropathie. Springer, pp 153–170Google Scholar
  30. 30.
    Edmonds ME (1986) The neuropathic foot in diabetes. Part I: Blood flow. Diabetic Medicine 3:111–115PubMedCrossRefGoogle Scholar
  31. 31.
    Logerfo FW, Coffman JD (1984) Vascular and microvascular disease of the foot in diabetes. N Engl J Med 311:1615–1619PubMedCrossRefGoogle Scholar
  32. 32.
    Zlathin MB, Pathrin M, Sartoris DJ, Resmick D (1987) The diabetic foot. Radiol Clin North Am 25:1095–1105Google Scholar
  33. 33.
    Apelqvist J, Castenfors J, Larsson J, Stinstrom A, Agardh C-D (1989) Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care 12:373–378PubMedCrossRefGoogle Scholar
  34. 34.
    Rhodes GR, Skudder P Jr (1986) Salvage of ischemic diabetic foot: role of transcutaneous oxygen mapping and multiple configuration of in situ bypass. Am J Surg 152:165–171PubMedCrossRefGoogle Scholar
  35. 35.
    Scher K, Steele FJ (1988) The septic foot in patients with diabetes. Surgery 104:661–666PubMedGoogle Scholar
  36. 36.
    Levin ME (1987) The diabetic foot: pathophysiology, evaluation, and treatment. In: Levin WM, O’Neal LW (eds) The diabetic foot, 4th ed. St. Louis, MO, Mosby, pp 1–50Google Scholar
  37. 37.
    Brand PW (1983) The diabetic foot. In: Ellenberg M, Rifkin H (eds) Diabetes mellitus: theory and practice, 3rd ed. New Hyde Park, NY, Med Exam, pp 829–849Google Scholar
  38. 38.
    Müller MJ, Diamond JE, Sinacore DR, Delitto A, Blair III VP, Drury DA, Rose SJ (1989) Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care 12:384–388CrossRefGoogle Scholar
  39. 39.
    Edmonds ME (1987) Experience in a multidisciplinary diabetic foot clinic. In: Connor H, Boulton AJM, Ward JD (eds) The foot in diabetes. John Wiley & Sons Ltd, Chichester New York Brisbone Toronto Singapore, pp 121–133Google Scholar
  40. 40.
    Assai JP, Muklhauser I, Pernat A, Gfeller R, Jorgens V, Berger M (1985) Patient education as the basis for diabetes care in clinical practice. Diabetologia 28:602–613Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • Wilhelm Krone
  • Dirk Müller-Wieland

There are no affiliations available

Personalised recommendations